261 Lesion characterization with ferumoxytol MRI in patients with advanced solid tumors and correlation with treatment response to MM-398, nanoliposomal irinotecan (nal-IRI) von Ramanathan, R.K, Korn, R.L, Sachdev, J.C, Fetterly, G.J, Jameson, G, Marceau, K, Marsh, V, Raghunand, N, Prey, J, Klinz, S.G, Kim, J, Bayever, E, Fitzgerald, J.B

Volltext

15P Efficacy of cabozantinib after immune checkpoint inhibition in a syngeneic tumor model von Rolland, S., Klinz, S.G., Chaumeron, S., Meyer-Losic, F., Hillairet de Boisferon, M.

Volltext

Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models von Rolland, S., Klinz, S.G., Meyer-Losic, F., Nahkle, J., Delille, R., Hillairet de Boisferon, M.

Volltext